Apollo Hospitals Enterprise Limited vs Suven Life Sciences Limited

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Suven Life Sciences Limited (SUVEN) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Apollo Hospitals Enterprise Limited leads APOLLOHOSP vs SUVEN on 11 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability40
  • Growth10
  • Size & financial health31

Valuation

APOLLOHOSP takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
-29.00
13.46
P/B ratio
14.92
0.22%
Dividend yield
0.00%
₹135.04
EPS
₹-10.48

Profitability

APOLLOHOSP takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
-46.73%
17.31%
Return on capital
-45.42%
14.94%
EBITDA margin
-4001.00%
7.94%
Net margin
-3942.86%

Growth

APOLLOHOSP takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
-20.22%
33.35%
Profit CAGR (3Y) even
—

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹8,583 Cr
₹25,229 Cr
Revenue
₹7 Cr
₹2,003 Cr
Net profit
₹-276 Cr
0.90
Debt / equity
0.03
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.98 times its book value"]
Suven Life Sciences Limited
  • + ["Company is almost debt free."]
  • − ["Stock is trading at 14.51 times its book value", "The company has delivered a poor sales growth of -11.4% over past five years.", "Company has a low return on equity of -65.4% over last 3 years.", "Company reported a net loss of ₹276 Cr in its latest financial year."]
Apollo Hospitals Enterprise Limited full analysis Suven Life Sciences Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.